MLA
Davies, Janine M, et al. Phospho-erk and Akt Status, but Not Kras Mutation Status, Are Associated with Outcomes In Rectal Cancer Treated with Chemoradiotherapy. BioMed Central Ltd, 2011. https://doi.org/10.17615/2nvs-gt85
APA
Davies, J., Trembath, D., Deal, A., Funkhouser, W., Calvo, B., Finnegan, T., Weck, K., Tepper, J., & O'neil, B. (2011). Phospho-ERK and AKT status, but not KRAS mutation status, are associated with outcomes in rectal cancer treated with chemoradiotherapy. BioMed Central Ltd. https://doi.org/10.17615/2nvs-gt85
Chicago
Davies, Janine M, Dimitri G Trembath, Allison M Deal, William Funkhouser, Benjamin F Calvo, Timothy Finnegan, Karen E Weck et al. 2011. Phospho-Erk and Akt Status, but Not Kras Mutation Status, Are Associated with Outcomes In Rectal Cancer Treated with Chemoradiotherapy. BioMed Central Ltd. https://doi.org/10.17615/2nvs-gt85